Logo Image
|Videos|November 1, 2022

Highlighting IDWeek Abstracts With Thomas Lodise, PharmD, PhD

Author(s)Nina Cosdon

Lodise breaks down significant findings from his 8 IDWeek 2022 posters.

It was a busy IDWeek conference for Thomas Lodise, PharmD, PhD.

Lodise is a professor at Albany College of Pharmacy and Health Sciences, as well as an infectious diseases clinical pharmacy specialist at the Stratton VA Medical Center. He took a break from these, however, to step into the role of researcher.

With 8 posters to share at IDWeek 2022, Lodise sat down with Contagion to disseminate his various studies. The topics ranged from urinary tract infections (UTIs), to fungal infections, to antimicrobial stewardship. “It really spans the spectrum of my different interests,” he said. “I do think they have a lot of clinical applicability.”

In this exclusive interview, Lodise describes highlights from his research findings.

“Each one of these abstracts really provides some important information for clinicians,” said Lodise. “Every one of these projects offers some clinical insights into challenging-to-treat patients, identifying some potential unmet needs.

Related to this article

View more
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Read more